| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/15/2008 | CA2698826A1 New antigens for paratuberculosis diagnosis and vaccination |
| 05/15/2008 | CA2679859A1 Method for detecting and controlling cancer |
| 05/15/2008 | CA2669731A1 Anti-human dlk-1 antibody showing anti-tumor activity in vivo |
| 05/15/2008 | CA2669205A1 Agonist trkb antibodies and uses thereof |
| 05/15/2008 | CA2668883A1 Procedure for expressing a tbpb protein on the bacterial surface of an attenuated oral live vaccine as prototype of a meningitis b vaccine |
| 05/15/2008 | CA2668854A1 Quality control methods for oil-in-water emulsions containing squalene |
| 05/15/2008 | CA2668834A1 Stabilization of vaccines by lyophilization |
| 05/15/2008 | CA2668704A1 Carbohydrate specific cellular immunity inducing microorganisms and fractions thereof |
| 05/15/2008 | CA2668632A1 Feline vaccines against avian influenza |
| 05/15/2008 | CA2668607A1 Nonoparticles of paclitaxel and albumin in combination with bevacizumab against cancer |
| 05/15/2008 | CA2668603A1 Microorganisms or fractions thereof capable of activating cellular immunity against carbohydrates |
| 05/15/2008 | CA2668417A1 Alphavirus and alphavirus replicon particle formulations and methods |
| 05/15/2008 | CA2668405A1 Canine lyme disease vaccine |
| 05/15/2008 | CA2668131A1 Antagonists of pcsk9 |
| 05/15/2008 | CA2667894A1 Antagonists of pcsk9 |
| 05/15/2008 | CA2667869A1 Antagonists of pcsk9 |
| 05/15/2008 | CA2667655A1 Crystalline anti-htnfalpha antibodies |
| 05/15/2008 | CA2666308A1 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 05/15/2008 | CA2666306A1 4-1 bb ligand in inflammatory diseases |
| 05/15/2008 | CA2664628A1 Novel neutralizing immunogen (nimiv) of rhinovirus and its use for vaccine applications |
| 05/14/2008 | EP1921149A1 Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof |
| 05/14/2008 | EP1921146A1 Recombinant vectors based on the modified ankara virus (mav) as preventive and therapeutic vaccines against aids |
| 05/14/2008 | EP1921137A1 Antibody having inhibitory effect on amyloid fibril formation |
| 05/14/2008 | EP1921090A1 Genetically modified antibody composition |
| 05/14/2008 | EP1921089A1 Cytotoxic t-cell epitope peptide and use thereof |
| 05/14/2008 | EP1920783A1 Recombinant RSV virus expression systems and vaccines |
| 05/14/2008 | EP1920782A1 Carboyhdrate specific cellular immunity inducing microorganisms and fractions thereof |
| 05/14/2008 | EP1920781A1 Compositions comprising a core-1 positive microorganism and their use for the treatment or prophylaxis of tumors |
| 05/14/2008 | EP1920778A2 A composition, its preparation method and its use |
| 05/14/2008 | EP1920774A1 Composition containing fucoidan or fucoidan hydrolysate and immunopotentiating material |
| 05/14/2008 | EP1920066A1 Cancerous disease modifying antibodies |
| 05/14/2008 | EP1920065A2 Anti-alpha v beta 6 antibodies and uses thereof |
| 05/14/2008 | EP1919957A2 Cd33-specific single-chain immunotoxin and method of use |
| 05/14/2008 | EP1919955A1 Cancerous disease modifying antibodies |
| 05/14/2008 | EP1919954A2 Immunomodulating tumor necrosis factor receptor 25 (tnfr25) agonists, antagonists and immunotoxins |
| 05/14/2008 | EP1919950A1 Optimized fc variants |
| 05/14/2008 | EP1919940A2 Antigenic peptides and their use |
| 05/14/2008 | EP1919505A2 Single dose use of cd20-specific binding molecules |
| 05/14/2008 | EP1919503A2 Identification and engineering of antibodies with variant fc regions and methods of using same |
| 05/14/2008 | EP1687026B1 Method for the treatment of multiple sclerosis by inhibiting il-17 activity |
| 05/14/2008 | EP1633882B1 Diagnostics and therapeutics for diseases associated with puromycin-insensitive leucyl-specific aminopeptidase (pils) |
| 05/14/2008 | EP1592444B1 Canine vaccines against bordetella bronchiseptica |
| 05/14/2008 | EP1572087B1 Antibodies against cancer antigen tmeff2 and uses thereof |
| 05/14/2008 | EP1506009B1 Beta-glucan-based anti-fungal vaccines |
| 05/14/2008 | EP1453531B1 Use of hmgb proteins and nucleic acids that code therefor |
| 05/14/2008 | EP1278540B1 Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 05/14/2008 | EP1235934B1 Screening method for candidate drugs |
| 05/14/2008 | EP1220948B1 Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders |
| 05/14/2008 | EP1171159B1 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv) |
| 05/14/2008 | EP1087997B1 Monoclonal antibodies directed against the g3bp protein, and uses |
| 05/14/2008 | EP1035132B1 Monoclonal antibody inducing apoptosis |
| 05/14/2008 | EP1017418B1 Vaccine composition for preventing or treating c hepatitis |
| 05/14/2008 | EP1003552B1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION |
| 05/14/2008 | EP0840749B1 The h-y antigen |
| 05/14/2008 | EP0833929B1 Chimeric antibodies for delivery of antigens to selected cells of the immune system |
| 05/14/2008 | EP0811075B1 A method for the isolation and purification of lipid cell-wall components |
| 05/14/2008 | EP0783313B1 Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies |
| 05/14/2008 | EP0772437B9 Compositions for delivery of genetic material |
| 05/14/2008 | EP0635132B2 Broadly reactive opsonic antibodies that react with common staphylococcal antigens |
| 05/14/2008 | EP0471726B2 Acellular vaccine |
| 05/14/2008 | CN201058029Y System for gathering and producing autoserum eye water |
| 05/14/2008 | CN101180313A Fermentation process for the production of diphtheria toxin |
| 05/14/2008 | CN101180079A Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 05/14/2008 | CN101180078A Combination |
| 05/14/2008 | CN101180077A New combination |
| 05/14/2008 | CN101180076A Use of an influenza virus an oil-in-water emulsion adjuvant to induce CD4 T-cell and/or improved B-memory cell response |
| 05/14/2008 | CN101180075A Vaccines |
| 05/14/2008 | CN101180072A Methods of using death receptor agonists and egfr inhibitors |
| 05/14/2008 | CN101180067A Combination consisting of a histological or cytological fixing solution and of one or more photoactivatable compounds of the family of quinones, in particular, hypericin, hypocrellin a and hyprcrellin |
| 05/14/2008 | CN101177684A Sheep brucella M5 strain ribosome protein L7/L12 gene, encoding protein and uses thereof |
| 05/14/2008 | CN101177451A Micrococcus pyogenes adhesion functional peptide and coded sequence thereof |
| 05/14/2008 | CN100387719C Coding of thermal sensitive toxin gene of bacillus coli, expressing carrier and application thereof |
| 05/14/2008 | CN100387718C Proteinase K resistant surface protein of neisseria meningitidis |
| 05/14/2008 | CN100387713C Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAs encoding the same |
| 05/14/2008 | CN100387622C Strategically modified hepatitis b core proteins and their derivatives |
| 05/14/2008 | CN100387621C Production of antihuman antigen receptors and use thereof |
| 05/14/2008 | CN100387618C Acellular pertussis vaccines and method of preparation thereof |
| 05/14/2008 | CN100387617C HIV peptides, antigens, vaccine compositions, immunoassay kit and method of detecting |
| 05/14/2008 | CN100387616C Method for obtaining antigenic structures enhancing specific cross reactivity |
| 05/14/2008 | CN100387301C Materials and methods for immunizing against fiv infection. |
| 05/14/2008 | CN100387300C Multivalent huma-bovine retavirus vaccine |
| 05/14/2008 | CN100387299C Avian e. coli vaccine for protection against colibacillosis |
| 05/14/2008 | CN100387298C Vaccine composition |
| 05/14/2008 | CN100387297C Preparation process of cow mammitis vaccine |
| 05/14/2008 | CN100387218C Immune globulin G biological factor oral detergent |
| 05/13/2008 | US7371846 Chemokine coreceptor fusion for use prevention and treatment of viral infection; immunotherapy |
| 05/13/2008 | US7371837 Human virus causing respiratory tract infection and uses thereof |
| 05/13/2008 | US7371828 Extracellular signal-regulated kinase sequences and methods of production and use |
| 05/13/2008 | US7371821 Polypeptide of given sequence used as immunogen; cytokine adjuvant; |
| 05/13/2008 | US7371819 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 05/13/2008 | US7371754 Tyrosine kinase inhibitors |
| 05/13/2008 | US7371736 detecting tumors via microarray analysisof transfection pattern of cancer marker gene; antitumor agents; anticancer agents |
| 05/13/2008 | US7371726 Neutralizing GDF8 epitope-based growth enhancing vaccine |
| 05/13/2008 | US7371723 Therapeutic agents comprising pro-apoptotic proteins |
| 05/13/2008 | US7371574 Antibody antagonists of VE-cadherin without adverse effects on vascular permeability |
| 05/13/2008 | US7371572 A conjugated drug contains virus-like particle is joined to the antigen by a biotin molecule; bioassay; inhibiting HIV infection, viral infection |
| 05/13/2008 | US7371571 Recombinant mycobacteria overexpressing D-alanine ligase gene and uses therefore |
| 05/13/2008 | US7371535 Detect binding with cells transfected with DNA |
| 05/13/2008 | US7371525 Therapeutic nucleic acid for use in diagnosis, prevention and treatment of respiratory system disorders; RNA interference |
| 05/13/2008 | US7371417 plant extracts used as adjuvants for DNA vaccines, to improve immune responses in mammals |